Furthermore, the authors demonstrated that the expression level of this protein shows a negative correlation with the stage of cancer development (AJCC staging), and survival analysis reveals that Barx2 expression level is an independent prognostic factor for NSCLC patients. The gene discussed is BARX2; the disease is cancer.